Primary care research and clinical practice: Gastroenterology

Postgraduate Medical Journal

Volumn 84, Issue 995, 2008, Pages 454-458

  Jones, R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ARTICLE; CELIAC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; COST OF ILLNESS; DIGESTIVE SYSTEM CANCER; DYSPEPSIA; ENTERITIS; GASTRITIS; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEALTH PERSONNEL ATTITUDE; HUMAN; IRRITABLE COLON; MEDICAL RESEARCH; PATIENT ATTITUDE; PRIMARY MEDICAL CARE;

FAMILY PRACTICE; GASTROINTESTINAL DISEASES; HEALTH SERVICES RESEARCH; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PROFESSIONAL PRACTICE;

EID: 55349130660     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2008.068361     Document Type: Article

References (45)

1. Jones R, Stevens R. Management of common gastrointestinal disorders in general practice: PCSG National Survey 2004. www.pcsg.org.uk.
2. Seifert B, Rubin G, de Wit N, et al. The management of common gastrointestinal disorders in general practice: a survey by the European Society for Primary Care Gastroenterology (ESPCG) in six European countries. Dig Liv Dis 2008;40:659-66.
3. Rosen R, Stevens R, Jones R. General practitioners with special clinical interests. BMJ 2003;327:460-2.
4. Finch R. When is a polyclinic not a polyclinic? BMJ 2008;336:916-8.
5. Majeed A, Lester H, Bindman A. Improving the quality of care with performance indicators. BMJ 2007;335:916-8.
6. Moayyedi P, Soo S, Deeks J, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000;321:659-64.
7. Moayyedi P, Soo S, Deeks J, et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews (4): CD001960, 2006.
8. Jones RH, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-2.
9. Jones RH, Lydeard S, Hobbs FDR, et al. Dyspepsia in England and Scotland. Gut 1990;31:401-5.
10. Jones RH, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
11. Crosland A, Jones R. Rectal bleeding: prevalence and consultation behaviour. BMJ 1995;311:486-8.
12. Hin H, Bird G, Fisher P, et al. Coeliac disease in primary care: case finding study. BMJ 1999;318:164-7.
13. Rubin GP, Hungin AP, Kelly PJ, et al. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553-9.
14. Rubin GP, Hungin APS, Chinn DJ, et al. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment Pharmacol Ther 2004;19:529-35.
15. Fry J. Common diseases. Lancaster: MTP Press, 1979.
16. Jones RH, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract 1992;46:95-7.
17. Agreus L, Svardsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-80.
18. Muris JW, Starmans R, Fijten GH, et al. One-year prognosis of abdominal complaints in general practice: a prospective study of patients in whom no organic cause is found. Br J Gen Pract 1996;46:715-9.
19. Wallander MA, Johansson S, Ruigomez A, et al. Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 2007b;24:403-11.
20. Jones R, Latinovic R, Charlton J, et al. Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database. Aliment Pharmacol Ther 2006;24:879-6.
21. Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al. Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice. Chest 2005;128:85-93.
22. Lydeard S, Jones RH. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495-8.
23. Kettell J, Jones RH, Lydeard S. Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. Br J Gen Pract 1992;42:459-61.
24. Koloski NA, Boyce PM. Talley NJ. Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci 2005;50:153-62.
25. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol 2006;18:1101- 9.
26. Hungin AP, Rubin GP, O'Flanagan H. Long-term prescribing of proton pump inhibitors in general practice. Br J Gen Pract 1999;49:451- 3.
27. Raghunath AS, Hungin APS, Comford CS, et al. Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners. Digestion 2005;72:212-8.
28. Armstrong D, Reybum H, Jones R. A study of general practitioners' reasons for changing their prescribing behaviour. BMJ 1996;312:949-52.
29. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52-7.
30. Jones R, Coyne K, Wiklund I. The gastro-oesophageal reflux disease impact scale - a patient management tool for primary care. Aliment Pharmacot Ther 2007;25:1451-9.
31. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-92.
32. Jones RH. Upper gastrointestinal endoscopy - a view from general practice. J R Coll Gen Pract 1986;36:6-8.
33. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-6.
34. Lassen AT, Pedersen FM, Bytzer P, et al. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management. Lancet 2000;356:455-60.
35. Jones R, Latinovic R, Charlton J, et al. Alarm symptoms in the early diagnosis of cancer in primary care. BMJ 2007;334:1040.
36. Johansson T, Petersen H. Kristensen P, et al. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. Scan J Gastroenterol 1992;27:189-95.
37. Jones RH, Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg bd in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997;11:541-6.
38. Jones R, Crouch SL. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia. Aliment Pharmacol Ther 1999;13:413-9.
39. Hungin AP, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999;49:463-4.
40. Jones RH, Holtmann G, Rodrigo L, et al. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients. Aliment Pharmacol Ther 1999;13:1419-27.
41. Kennedy T, Jones R. Darnley S, et al. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomized controlled trial. BMJ 2005;331:435-7.
42. McCrone P, Knapp M, Kennedy T, et al. Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome, Eur J Gastroenterol Hepatol 2008;20:255-63.
43. British Society of Gastroenterology. Guidelines on the irritable bowel syndrome: mechanisms and practical management, http://gut.bmj.com/onlinefirst.dtl. May 2007.
44. Kennedy TM, Jones RH. The epidemiology of hysterectomy and irritable bowel syndrome in a UK population, Int J Clin Pfact 2000;54:647-60.
45. Kennedy TM, Jones RH. Epidemiology of chotecystectomy and irritable bowel syndrome in a UK population. Br J Surgery 2000;12:1658-64